Thyroid hormones and bone development

Minerva Endocrinologica

Volumn 36, Issue 1, 2011, Pages 71-85

  Combs, C E ^a   Nicholls, J J ^a   Duncan Bassett, J H ^a   Williams, G R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bone development; Receptors, thyroid hormone; Thyroid hormones

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; CALCITRIOL; COLLAGEN TYPE 10; COLONY STIMULATING FACTOR 1; CORTICOSTEROID; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; EPHRIN RECEPTOR B4; ESTROGEN; FIBROBLAST GROWTH FACTOR 1; LIOTHYRONINE; MEMBRANE PROTEIN; MONOCARBOXYLATE TRANSPORTER 10; MONOCARBOXYLATE TRANSPORTER 8; ORGANIC ACID TRANSPORTER PROTEIN 1C1; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; PROTIRELIN; SOBETIROME; SOMATOMEDIN; THYROID HORMONE; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE; THYROXINE DEIODINASE; TRANSCRIPTION FACTOR PAX8; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT4 PROTEIN;

ALLAN HERNDON DUDLEY SYNDROME; APOPTOSIS; AUTOIMMUNITY; BLOMSTRAND CHONDROPLASIA; BONE DEVELOPMENT; BONE MASS; BONE MATURATION; BONE REMODELING; BONE TURNOVER; CARTILAGE CELL; CELL INTERACTION; CELL PROLIFERATION; CELL TRANSPORT; CHILDHOOD DISEASE; CHONDRODYSPLASIA; CONGENITAL HYPOTHYROIDISM; CORTICAL BONE; DELAYED DIAGNOSIS; DIAPHYSIS; DISEASE SEVERITY; DWARFISM; EARLY INTERVENTION; ENCHONDRAL OSSIFICATION; FEEDBACK SYSTEM; GENE DELETION; GENETIC DISORDER; GRAVES DISEASE; GROWTH DISORDER; GROWTH PLATE; GROWTH RETARDATION; HORMONE SENSITIVITY; HUMAN; HYPOPHYSIS THYROID SYSTEM; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; JANSEN METAPHYSEAL CHONDRODYSPLASIA; KNOCKOUT MOUSE; LIOTHYRONINE BLOOD LEVEL; LOSS OF FUNCTION MUTATION; MESENCHYMAL STEM CELL; NEWBORN DISEASE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PERICHONDRIUM; PERIOSTEUM; POSTNATAL DEVELOPMENT; PROTEIN EXPRESSION; REVIEW; SHORT STATURE; SIGNAL TRANSDUCTION; THYROID FOLLICLE CELL; THYROID HORMONE RESISTANCE; THYROTOXICOSIS; TSH SECRETING CELL;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE REMODELING; EVIDENCE-BASED MEDICINE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHYROIDISM; THYROID HORMONES; THYROTROPIN; TRIIODOTHYRONINE;

EID: 79960019112     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Rivkees SA, Bode HH, Crawford JD. Long-term growth in juvenile acquired hypothyroidism: the failure to achieve normal adult stature. N Engl J Med 1988;318:599-602. (Pubitemid 18083591)
2. Boccone L, Mariotti S, Dessi V, Pruna D, Meloni A, Loudianos G. Allan-Herndon-Dudley syndrome (AHDS) cauzed by a novel SLC16A2 gene mutation showing severe neurologic features and unexpectedly low TRH-stimulated serum TSH. Eur J Med Genet 2010 [Epub ahead of print].
3. Friesema EC, Grueters A, Biebermann H, Krude H, von MA, Reeser M et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004;364:1435-7. (Pubitemid 39370719)
4. Friesema EC, Jansen J, Heuer H, Trajkovic M, Bauer K, Visser TJ. Mechanisms of disease: psychomotor retardation and high T3 levels cauzed by mutations in monocarboxylate transporter 8. Nat Clin Pract Endocrinol Metab 2006;2:512-23. (Pubitemid 44353292)
5. Kopp P, van SJ, Parma J, Duprez L, Gerber H, Joss E et al. Brief report: congenital hyperthyroidism cauzed by a mutation in the thyrotropin-receptor gene. N Engl J Med 1995;332:150-4.
6. Segni M, Leonardi E, Mazzoncini B, Pucarelli I, Pasquino AM. Special features of Graves' disease in early childhood. Thyroid 1999,9:871-7.
7. Weiss RE, Refetoff S. Treatment of resistance to thyroid hormone - primum non nocere. J Clin Endocrinol Metab 1999;84:401-4. (Pubitemid 29075659)
8. Weiss RE, Refetoff S. Effect of thyroid hormone on growth. Lessons from the syndrome of resistance to thyroid hormone. Endocrinol Metab Clin North Am 1996;25:719-30.
9. Lassova L, Niu Z, Golden EB, Cohen AJ, Adams SL. Thyroid hormone treatment of cultured chondrocytes mimics in vivo stimulation of collagen X mRNA by increasing BMP 4 expression. J Cell Physiol 2009;219:595-605.
10. Jacenko O, LuValle PA, Olsen BR. Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage-to-bone transition. Nature 1993;365:56-61. (Pubitemid 23305568)
11. Sato S, Futakuchi M, Ogawa K, Asamoto M, Nakao K, Asai K et al. Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment. Cancer Sci 2008;99:316-23. (Pubitemid 351228486)
12. Matsuo K. Eph and ephrin interactions in bone. Adv Exp Med Biol 2010;658:95-103.
13. Bassett JH, Williams GR. Critical role of the hypothalamic-pituitary- thyroid axis in bone. Bone 2008;43:418-26.
14. St Germain DL, Galton VA, Hernandez A. Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology 2009;150:1097-107.
15. Plateroti M, Gauthier K, Domon-Dell C, Freund JN, Samarut J, Chassande O. Functional interference between thyroid hormone receptor alpha (TRalpha) and natural truncated TRDeltaalpha isoforms in the control of intestine development. Mol Cell Biol 2001;21:4761-72. (Pubitemid 32588256)
16. Privalsky ML. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 2004;66:315-60. (Pubitemid 40614447)
17. O'Shea PJ, Harvey CB, Suzuki H, Kaneshige M, Kaneshige K, Cheng SY et al. A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. Mol Endocrinol 2003;17:1410-24. (Pubitemid 36819960)
18. Capelo LP, Beber EH, Fonseca TL, Gouveia CH. The monocarboxylate transporter 8 and L-type amino acid transporters 1 and 2 are expreszed in mouse skeletons and in osteoblastic MC3T3-E1 cells. Thyroid 2009;19:171-80.
19. Williams AJ, Robson H, Kester MH, van Leeuwen JP, Shalet SM, Visser TJ et al. Iodothyronine deiodinase enzyme activities in bone. Bone 2008;43:126-34.
20. Williams GR, Bland R, Sheppard MC. Characterization of thyroid hormone (T3) receptors in three osteosarcoma cell lines of distinct osteoblast phenotype: interactions among T3, vitamin D3, and retinoid signaling. Endocrinology 1994;135:2375-85.
21. Robson H, Siebler T, Stevens DA, Shalet SM, Williams GR. Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation. Endocrinology 2000;141:3887-97.
22. Stevens DA, Hasserjian RP, Robson H, Siebler T, Shalet SM, Williams GR. Thyroid hormones regulate hypertrophic chondrocyte differentiation and expression of parathyroid hormone-related peptide and its receptor during endochondral bone formation. J Bone Miner Res 2000;15:2431-42.
23. Abe E, Marians RC, Yu W, Wu XB, Ando T, Li Y et al. TSH is a negative regulator of skeletal remodeling. Cell 2003;115:151-62. (Pubitemid 37329579)
24. Walker DG. An assay of the skeletogenic effect of L-triiodothyronine and its acetic acid analogue in immature rats. Bull Johns Hopkins Hosp 1957;101:101-14.
25. Capelo LP, Beber EH, Huang SA, Zorn TM, Bianco AC, Gouveia CH. Deiodinase-mediated thyroid hormone inactivation minimizes thyroid hormone signaling in the early development of fetal skeleton. Bone 2008;43:921-30.
26. Chiellini G, Apriletti JW, Yoshihara HA, Baxter JD, Ribeiro RC, Scanlan TS. A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chem Biol 1998;5:299-306. (Pubitemid 28309983)
27. Freitas FR, Capelo LP, O'Shea PJ, Jorgetti V, Moriscot AS, Scanlan TS et al. The thyroid hormone receptor beta-specific agonist GC-1 selectively affects the bone development of hypothyroid rats. J Bone Miner Res 2005;20:294-304.
28. Mansouri A, Chowdhury K, Gruss P. Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet 1998;19:87-90. (Pubitemid 28242031)
29. Friedrichsen S, Christ S, Heuer H, Schafer MK, Mansouri A, Bauer K et al. Regulation of iodothyronine deiodinases in the Pax8-/- mouse model of congenital hypothyroidism. Endocrinology 2003;144:777-84.
30. Weiss RE, Chassande O, Koo EK, Macchia PE, Cua K, Samarut J et al. Thyroid function and effect of aging in combined hetero/homozygous mice deficient in thyroid hormone receptors alpha and beta genes. J Endocrinol 2002;172:177-85. (Pubitemid 34082956)
31. Flamant F, Poguet AL, Plateroti M, Chassande O, Gauthier K, Streichenberger N et al. Congenital hypothyroid Pax8(-/-) mutant mice can be rescued by inactivating the TRalpha gene. Mol Endocrinol 2002;16:24-32. (Pubitemid 34044495)
32. Bassett JH, Williams AJ, Murphy E, Boyde A, Howell PG, Swinhoe R et al. A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism. Mol Endocrinol 2008;22:501-12.
33. Chassande O, Fraichard A, Gauthier K, Flamant F, Legrand C, Savatier P et al. Identification of transcripts initiated from an internal promoter in the c-erbA alpha locus that encode inhibitors of retinoic acid receptor-alpha and triiodothyronine receptor activities. Mol Endocrinol 1997;11:1278-90. (Pubitemid 28041335)
34. Fraichard A, Chassande O, Plateroti M, Roux JP, Trouillas J, Dehay C et al. The T3R alpha gene encoding a thyroid hormone receptor is essential for postnatal development and thyroid hormone production. EMBOJ 1997;16:4412-20. (Pubitemid 27298194)
35. Gauthier K, Chassande O, Plateroti M, Roux JP, Legrand C, Pain B et al. Different functions for the thyroid hormone receptors TRalpha and TRbeta in the control of thyroid hormone production and postnatal development. EMBO J 1999;18:623-31. (Pubitemid 29057247)
36. Forrest D, Hanebuth E, Smeyne RJ, Everds N, Stewart CL, Wehner JM et al. Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: evidence for tissue-specific modulation of receptor function. EMBO J 1996;15:3006-15. (Pubitemid 26187749)
37. Bassett JH, O'Shea PJ, Sriskantharajah S, Rabier B, Boyde A, Howell PG et al. Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Mol Endocrinol 2007;21:1095-107.
38. Mittag J, Friedrichsen S, Heuer H, Polsfuss S, Visser TJ, Bauer K. Athyroid Pax8-/- mice cannot be rescued by the inactivation of thyroid hormone receptor alphal. Endocrinology 2005;146:3179-84. (Pubitemid 41002827)
39. Parrilla R, Mixson AJ, McPherson JA, McClaskey JH, Weintraub BD. Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. J Clin Invest 1991;88:2123-30.
40. Kaneshige M, Suzuki H, Kaneshige K, Cheng J, Wimbrow H, Barlow C et al. A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increazed mortality, infertility, and dwarfism in mice. Proc Natl Acad Sci U S A 2001;98:15095-100.
41. O'Shea PJ, Bassett JH, Sriskantharajah S, Ying H, Cheng SY, Williams GR. Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alphal or beta. Mol Endocrinol 2005;19:3045-59. (Pubitemid 41697720)
42. Marians RC, Ng L, Blair HC, Unger P, Graves PN, Davies TF. Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc Natl Acad Sci U S A 2002;99:15776-81.
43. Gu WX, Du GG, Kopp P, Rentoumis A, Albanese C, Kohn LD et al. The thyrotropin (TSH) receptor transmembrane domain mutation (Pro556-Leu) in the hypothyroid hyt/hyt mouse results in plasma membrane targeting but defective TSH binding. Endocrinology 1995;136:3146-53.
44. Galton VA, Wood ET, St Germain EA, Withrow CA, Aldrich G, St Germain GM et al. Thyroid hormone homeostasis and action in the type 2 deiodinase-deficient rodent brain during development. Endocrinology 2007;148:3080-8. (Pubitemid 46997018)
45. Galton VA, Schneider MJ, Clark AS, St Germain DL. Life without thyroxine to 3,5,3′-triiodothyronine conversion: studies in mice devoid of the 5′-deiodinases. Endocrinology 2009;150:2957-63.
46. Dentice M, Bandyopadhyay A, Gereben B, Callebaut I, Christoffolete MA, Kim BW et al. The Hedgehog-inducible ubiquitin ligase subunit WSB-I modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat Cell Biol 2005;7:698-705. (Pubitemid 40975751)
47. Hernandez A, Martinez ME, Fiering S, Galton VA, St GD. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest 2006;116:476-84. (Pubitemid 43228365)
48. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM et al. Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest 2007;117:627-35. (Pubitemid 46348521)
49. Ballock RT, Zhou X, Mink LM, Chen DH, Mita BC, Stewart MC. Expression of cyclin-dependent kinase inhibitors in epiphyseal chondrocytes induced to terminally differentiate with thyroid hormone. Endocrinology 2000;141:4552-7. (Pubitemid 32055133)
50. Stevens DA, Harvey CB, Scott AJ, O'Shea PJ, Barnard JC, Williams AJ et al. Thyroid hormone activates fibroblast growth factor receptor-1 in bone. Mol Endocrinol 2003;17:1751-66. (Pubitemid 37072292)
51. Varga F, Rumpler M, Zoehrer R, Turecek C, Spitzer S, Thaler R et al. T3 affects expression of collagen I and collagen cross-linking in bone cell cultures. Biochem Biophys Res Commun 2010 [Epub ahead of print].
52. Kanatani M, Sugimoto T, Sowa H, Kobayashi T, Kanzawa M, Chihara K. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction. J Cell Physiol 2004;201:17-25.
53. Allain TJ, Chambers TJ, Flanagan AM, McGregor AM. Tri-iodothyronine stimulates rat osteoclastic bone resorption by an indirect effect. J Endocrinol 1992;133:327-31.
54. Britto JM, Fenton AJ, Holloway WR, Nicholson GC. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 1994;134:169-76. (Pubitemid 24021985)
55. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 2001;229:141-62.
56. Ezzat S, Laks D, Oster J, Melmed S. Growth hormone regulation in primary fetal and neonatal rat pituitary cell cultures: the role of thyroid hormone. Endocrinology 1991;128:937-43.
57. Lewinson D, Bialik GM, Hochberg Z. Differential effects of hypothyroidism on the cartilage and the osteogenic process in the mandibular condyle: recovery by growth hormone and thyroxine. Endocrinology 1994;135:1504-10. (Pubitemid 24307528)
58. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 2002;157:303-14. (Pubitemid 34839826)
59. Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML et al. High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 2003;18:960-74. (Pubitemid 37294932)
60. Wang L, Shao YY, Ballock RT. Thyroid hormone interacts with the Wnt/beta-catenin signaling pathway in the terminal differentiation of growth plate chondrocytes. J Bone Miner Res 2007;22:1988-95. (Pubitemid 351229315)
61. Wang L, Shao YY, Ballock RT. Carboxypeptidase Z (CPZ) links thyroid hormone and Wnt signaling pathways in growth plate chondrocytes. J Bone Miner Res 2009;24:265-73.
62. Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 2004;18:1072-87. (Pubitemid 38620246)
63. Barnard JC, Williams AJ, Rabier B, Chassande O, Samarut J, Cheng SY et al. Thyroid hormones regulate fibroblast growth factor receptor signaling during chondrogenesis. Endocrinology 2005;146:5568-80.
64. Stevens DA, Harvey CB, Scott AJ, O'Shea PJ, Barnard JC, Williams AJ et al. Thyroid hormone activates fibroblast growth factor receptor-1 in bone. Mol Endocrinol 2003;17:1751-66. (Pubitemid 37072292)
65. Barnard JC, Williams AJ, Rabier B, Chassande O, Samarut J, Cheng SY et al. Thyroid hormones regulate fibroblast growth factor receptor signaling during chondrogenesis. Endocrinology 2005;146:5568-80.
66. Karp SJ, Schipani E, St-Jacques B, Hunzelman J, Kronenberg H, McMahon AP. Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. Development 2000;127:543-8. (Pubitemid 30093402)
67. Bassett JH, Williams GR. The skeletal phenotypes of TRalpha and TRbeta mutant mice. J Mol Endocrinol 2009;42:269-82.
68. Bassett JH, Swinhoe R, Chassande O, Samarut J, Williams GR. Thyroid hormone regulates heparan sulfate proteoglycan expression in the growth plate. Endocrinology 2006;147:295-305.
69. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 1996;273:613-22. (Pubitemid 26262108)
70. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 2000;6:743-50.
71. Cao X, Chen D. The BMP signaling and in vivo bone formation. Gene 2005;357:1-8. (Pubitemid 41267309)
72. Cohen AJ, Lassova L, Golden EB, Niu Z, Adams SL. Retinoids directly activate the collagen X promoter in prehypertrophic chondrocytes through a distal retinoic acid response element. J Cell Biochem 2006,99:269-78. (Pubitemid 44297970)
73. Volk SW, Luvalle P, Leask T, Leboy PS. A BMP responsive transcriptional region in the chicken type X collagen gene. J Bone Miner Res 1998;13:1521-9. (Pubitemid 28465292)
74. Saraiva PP, Teixeira SS, Padovani CR, Nogueira CR. Triiodothyronine (T3) does not induce Rankl expression in rat Ros 17/2.8 cells. Arq Bras Endocrinol Metabol 2008;52:109-13.
75. Varga F, Spitzer S, Klaushofer K. Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype. Calcif Tissue Int 2004;74:382-7.
76. Kim CH, Kim HK, Shong YK, Lee KU, Kim GS. Thyroid hormone stimulates basal and interleukin (IL)-1-induced IL-6 production in human bone marrow stromal cells: a possible mediator of thyroid hormone-induced bone loss. J Endocrinol 1999;160.97-102.
77. Siddiqi A, Burrin JM, Wood DF, Monson JP. Tri-iodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells. J Endocrinol 1998;157:453-61.
78. Siddiqi A, Monson JP, Wood DF, Besser GM, Burrin JM. Serum cytokines in thyrotoxicosis. J Clin Endocrinol Metab 1999;84:435-9. (Pubitemid 29075665)
79. Miura M, Tanaka K, Komatsu Y, Suda M, Yasoda A, Sakuma Y et al. A novel interaction between thyroid hormones and 1,25(OH)(2)D(3) in osteoclast formation. Biochem Biophys Res Commun 2002;291:987-94.
80. Schiller C, Gruber R, Ho GM, Redlich K, Gober HJ, Katzgraber F et al. Interaction of triiodothyronine with lalpha,25-dihydroxyvitamin D3 on interleukin-6-dependent osteoclast-like cell formation in mouse bone marrow cell cultures. Bone 1998;22:341-6. (Pubitemid 28177186)
81. Gauthier K, Plateroti M, Harvey CB, Williams GR, Weiss RE, Refetoff S et al. Genetic analysis reveals different functions for the products of the thyroid hormone receptor alpha locus. Mol Cell Biol 2001;21:4748-60. (Pubitemid 32588255)
82. Bassett JH, Nordstrom K, Boyde A, Howell PG, Kelly S, Vennstrom B et al. Thyroid status during skeletal development determines adult bone structure and mineralization. Mol Endocrinol 2007;21:1893-904. (Pubitemid 47173799)
83. Kaneshige M, Kaneshige K, Zhu X, Dace A, Garrett L, Carter TA et al. Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci U S A 2000,97:13209-214.
84. Bassett JH, Boyde A, Howell PG, Bassett RH, Galhford TM, Archanco M et al. Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proc Natl Acad Sci U S A 2010;107:7604-9.